Ikerian AG (formerly RetinAI Medical) is a fast-growing medical device software company headquartered in Bern, Switzerland. Our mission is to enable the right decisions sooner in healthcare, through transformative AI & data management solutions for disease screening and monitoring. Join our diverse team of entrepreneurs, developers, researchers, and commercial experts who are collectively shaping the future of healthcare.
We are looking for an experienced clinician who is well versed in all aspects of ophthalmology. This person will be responsible for building relationships with a clinical site’s research coordinators and PI’s, performing a medical record review of pre-identified patients to evaluate clinical trial eligibility based on a sponsor’s protocol, delivering the results to the sites, and monitoring and collecting the outcomes. You will also be responsible for managing the sponsor relationship as it pertains to the individual project, updating them and meeting with them as contractually agreed, and knowing when to include a commercial team member or point of escalation if needed.
This role will work closely with our data science and research team to ensure quality and accuracy of client deliverables as well as serving as an SME for consulting on eligibility criteria when needed.
Additional tasks may be assigned based on necessity, so the ability to remain flexible and be willing to assume additional responsibilities as our company grows is a must.
Key Responsibilities
Requirements
Benefits

RetinAI is a Swiss & US-based software company improving and supporting R&D of first-in-human drug candidates, supercharging management and oversight of clinical trials and enabling the research needed to elevate the quality of care on patients with eye diseases.
We achieve this goal by building tools to collect, analyze and to organize health data. Our fundamental belief is that in the future every patient will use drugs alongside a digital application that will enable them and their physicians to better assess the right drug, in the right amount and the right frequency for patients.